Targeting Smyd3 by next-generation antisense oligonucleotides suppresses liver tumor growth.

Kontaki, Haroula; Koukaki, Marina; Vasilarou, Maria; Giakountis, Antonis; Deligianni, Elena; Luo, Xiaolin; Kim, Youngsoo; Talianidis, Iannis.

Afiliação

Kontaki H; Institute of Molecular Biology and Biotechnology, FORTH, 70013 Herakleion, Crete, Greece.
Koukaki M; Institute of Molecular Biology and Biotechnology, FORTH, 70013 Herakleion, Crete, Greece.
Vasilarou M; Institute of Molecular Biology and Biotechnology, FORTH, 70013 Herakleion, Crete, Greece.
Giakountis A; Department of Biology, University of Crete, 70013 Herakleion, Crete, Greece.
Deligianni E; Department of Biochemistry and Biotechnology, University of Thessaly, Larissa 41500, Greece.
Luo X; Institute of Molecular Biology and Biotechnology, FORTH, 70013 Herakleion, Crete, Greece.
Kim Y; Ionis Pharmaceuticals, Carlsbad, CA, USA.
Talianidis I; Ionis Pharmaceuticals, Carlsbad, CA, USA.

iScience ; 24(5): 102473, 2021 May 21.

Article em En | MEDLINE | ID: mdl-34113819